Active Ingredient(s):Delafloxacin FDA Approved: * June 19, 2017 Pharm Company: *MELINTA THERAPEUTICS INC Category:Antibiotics
Delafloxacin sold under the brand name Baxdela among others, is a fluoroquinolone antibiotic used to treat acute bacterial skin and skin structure infections.
1 Medical use
2 Adverse effects
8 External links
Delafloxacin is indicated to treat adults with acute bacterial skin and skin structure infections (ABSSSI) caused by designated susceptible bacteria or adults with community-acq...
* May have multiple approval dates, manufacturers, or labelers.